Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.0750
-0.0050 (-6.25%)
Oct 30, 2026, 2:11 PM EDT
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 25.82 million as of October 30, 2026. It is the 37,345th most valuable company in the world and the 1,183rd biggest in Canada. Its market cap has decreased by 10.11% in one year.
Market Cap
25.82M
Enterprise Value
155.57M
Revenue
n/a
Global Rank
Country Rank
#1,183 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 25.82M, an increase of 12.56%. That is a compound annual growth rate of 0.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 25.82M | -10.20% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 41.54M |
| BriaCell Therapeutics | 40.45M |
| Microbix Biosystems | 39.72M |
| MedMira | 35.09M |
| Sona Nanotech | 34.38M |
| ME Therapeutics Holdings | 33.43M |
| Defence Therapeutics | 26.53M |
| Telescope Innovations | 25.06M |